Raily Aesthetic Medicine International Holdings Limited (HK:2135) has released an update.

Raily Aesthetic Medicine International Holdings Limited successfully held its 2024 Annual General Meeting on June 28, where all proposed resolutions were unanimously passed by shareholders, including the re-election of executive directors, the re-appointment of Ernst & Young as auditors, and the approval of mandates related to share allotment and repurchase. The company also received approval for an increase in authorized share capital, reflecting a solid shareholder confidence in its corporate strategies and governance.

For further insights into HK:2135 stock, check out TipRanks’ Stock Analysis page.